341 related articles for article (PubMed ID: 21323689)
1. Review article: remission rates achievable by current therapies for inflammatory bowel disease.
Peyrin-Biroulet L; Lémann M
Aliment Pharmacol Ther; 2011 Apr; 33(8):870-9. PubMed ID: 21323689
[TBL] [Abstract][Full Text] [Related]
2. Medical therapy of IBD in 2009.
Harris A; Feller ER; Shah SA
Med Health R I; 2009 Mar; 92(3):78-81. PubMed ID: 19385382
[No Abstract] [Full Text] [Related]
3. Drug resistance in inflammatory bowel diseases.
Moreau J; Mas E
Curr Opin Pharmacol; 2015 Dec; 25():56-61. PubMed ID: 26645664
[TBL] [Abstract][Full Text] [Related]
4. General principles of medical therapy of inflammatory bowel disease.
Friedman S
Gastroenterol Clin North Am; 2004 Jun; 33(2):191-208, viii. PubMed ID: 15177534
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of chronic inflammatory bowel diseases].
Lémann M
Bull Acad Natl Med; 2007 Jun; 191(6):1125-41; discussion 1141. PubMed ID: 18402168
[TBL] [Abstract][Full Text] [Related]
6. The future of inflammatory bowel disease care.
Sandborn WJ
Rev Gastroenterol Disord; 2009; 9(3):E69-77. PubMed ID: 19898267
[TBL] [Abstract][Full Text] [Related]
7. [Benefits and risks of immunosuppression in chronic inflammatory bowel diseases].
Rogler G
Dtsch Med Wochenschr; 2008 Sep; 133(38):1917-21. PubMed ID: 18785084
[No Abstract] [Full Text] [Related]
8. Biological therapies in inflammatory bowel disease: top-down or bottom-up?
Oldenburg B; Hommes D
Curr Opin Gastroenterol; 2007 Jul; 23(4):395-9. PubMed ID: 17545775
[TBL] [Abstract][Full Text] [Related]
9. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
[TBL] [Abstract][Full Text] [Related]
10. Medical management of the pregnant patient with inflammatory bowel disease.
Steinlauf AF; Present DH
Gastroenterol Clin North Am; 2004 Jun; 33(2):361-85, xi. PubMed ID: 15177544
[TBL] [Abstract][Full Text] [Related]
11. Management of inflammatory bowel disease in adults.
Katz JA
J Dig Dis; 2007 May; 8(2):65-71. PubMed ID: 17532817
[TBL] [Abstract][Full Text] [Related]
12. Biological therapies of inflammatory bowel disease.
Bai A; Peng Z
Immunotherapy; 2010 Sep; 2(5):727-42. PubMed ID: 20874655
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory bowel disease.
Podolsky DK
N Engl J Med; 2002 Aug; 347(6):417-29. PubMed ID: 12167685
[No Abstract] [Full Text] [Related]
14. Therapeutic approaches in inflammatory bowel disease based on the immunopathogenesis.
Siegmund B; Zeitz M
Rocz Akad Med Bialymst; 2004; 49():22-30. PubMed ID: 15631310
[TBL] [Abstract][Full Text] [Related]
15. How effective are the usual treatments for Crohn's disease?
Bebb JR; Scott BB
Aliment Pharmacol Ther; 2004 Jul; 20(2):151-9. PubMed ID: 15233694
[TBL] [Abstract][Full Text] [Related]
16. Crohn's disease: current treatment options.
Akobeng AK
Arch Dis Child; 2008 Sep; 93(9):787-92. PubMed ID: 18456695
[TBL] [Abstract][Full Text] [Related]
17. [Treatment strategies for inflammatory bowel disease].
Lémann M; Allez M
Rev Prat; 2005 May; 55(9):984-92. PubMed ID: 16052969
[TBL] [Abstract][Full Text] [Related]
18. [Drug therapy and nutrition therapy of a young patient with Crohn disease].
Verkasalo M
Duodecim; 2003; 119(7):617-24. PubMed ID: 12762201
[No Abstract] [Full Text] [Related]
19. American Gastroenterological Association Institute medical position statement on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease.
Lichtenstein GR; Abreu MT; Cohen R; Tremaine W;
Gastroenterology; 2006 Mar; 130(3):935-9. PubMed ID: 16530531
[No Abstract] [Full Text] [Related]
20. Pharmacogenetics of inflammatory bowel disease.
Katsanos KH; Papadakis KA
Pharmacogenomics; 2014 Dec; 15(16):2049-62. PubMed ID: 25521361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
